RCW
LLY icon

Rheos Capital Works’s Eli Lilly LLY Stock Holding History

Rheos Capital Works’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42M Buy
+35,000
New +$35.8M 2.39% 10
2025
Q1 		– Sell
-27,000
Closed -$20.8M – 89
2024
Q4 		$20.8M Hold
27,000
– – 1.16% 30
2024
Q3 		$23.9M Sell
27,000
-34,400
-56% -$30.9M 1.25% 27
2024
Q2 		$55.6M Sell
61,400
-51,600
-46% -$41.3M 2.91% 7
2024
Q1 		$87.9M Buy
113,000
+28,000
+33% +$19.9M 4.21% 4
2023
Q4 		$49.5M Buy
+85,000
New +$49.6M 2.74% 6

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rheos Capital Works's LLY Position: Q2 2026 in Review

Rheos Capital Works opened a new position in Eli Lilly (LLY) in Q2 2026: 35,000 shares worth $42M. The stake represents 2.39% of the portfolio and ranks #10 among its holdings. This is a return to the name: Rheos Capital Works previously reported a position in LLY as recently as Q4 2024.

Rheos Capital Works first reported a position in LLY in Q4 2023 and has held it in 6 quarters since. The position peaked at $87.9M in Q1 2024. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rheos Capital Works held 35,000 shares of Eli Lilly worth $42M as of Q2 2026.
  • Eli Lilly was a new Rheos Capital Works position in Q2 2026.
  • Eli Lilly made up 2.39% of Rheos Capital Works's portfolio in Q2 2026, its #10 holding.
  • Rheos Capital Works first reported a position in Eli Lilly in Q4 2023 and has held it in 6 quarters since.
  • Rheos Capital Works's Eli Lilly position peaked at $87.9M in Q1 2024.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rheos Capital Works's 13F filing for Q2 2026, filed 7 Aug 2026.